121 related articles for article (PubMed ID: 321161)
1. Cell-mediated immunity in an ageing population.
Girard JP; Paychère M; Cuevas M; Fernandes B
Clin Exp Immunol; 1977 Jan; 27(1):85-91. PubMed ID: 321161
[TBL] [Abstract][Full Text] [Related]
2. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
Catalona WJ; Tarpley JL; Potvin C; Chretien PB
Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immunity in systemic lupus erythematosus: alterations with advancing age.
Foad BS; Khullar S; Freimer EH; Kirsner AB; Sheon RP
J Lab Clin Med; 1975 Jan; 85(1):132-9. PubMed ID: 49381
[TBL] [Abstract][Full Text] [Related]
4. Effects of blood transfusion on cellular immunity.
Giacchino F; Belardi P; Coppo R; Quarello F; Alloatti S; Pozzato M; Giraudo G; Roccatello D; Basolo B; Boero R; Piccoli G
Proc Eur Dial Transplant Assoc; 1981; 18():465-8. PubMed ID: 7036167
[TBL] [Abstract][Full Text] [Related]
5. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
[TBL] [Abstract][Full Text] [Related]
6. Immune function in sarcoidosis. Studies on delayed hypersensitivity, B and T lymphocytes, serum immunoglobulins and serum complement components.
Tannenbaum H; Rocklin RE; Schur PH; Sheffer AL
Clin Exp Immunol; 1976 Dec; 26(3):511-9. PubMed ID: 795577
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immunity in the rheumatoid diseases. I. Skin testing and mitogenic responses in sero-negative arthritides.
Froebel K; Sturrock RD; Dick WC; MacSween RN
Clin Exp Immunol; 1975 Dec; 22(3):446-52. PubMed ID: 1083785
[TBL] [Abstract][Full Text] [Related]
8. Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production.
Woody JN; Ahmed A; Knudsen RC; Strong DM; Sell KW
J Clin Invest; 1975 May; 55(5):956-66. PubMed ID: 1091657
[TBL] [Abstract][Full Text] [Related]
9. Influence of adult thymectomy on immunocompetence in patients with myasthenia gravis.
Wijermans P; Oosterhuis HJ; Astaldi GC; Schellekens PT; Astaldi A
J Immunol; 1980 Apr; 124(4):1977-82. PubMed ID: 7189201
[TBL] [Abstract][Full Text] [Related]
10. Nutritional status and the nonspecific cellular and humoral immune response in esophageal carcinoma.
Haffejee AA; Angorn IB
Ann Surg; 1979 Apr; 189(4):475-9. PubMed ID: 109056
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte transformation during dinitrochlorobenzene contact sensitization. An in vitro and in vivo evaluation of the primary immune response in man.
Miller AE; Levis WR
J Clin Invest; 1973 Aug; 52(8):1925-30. PubMed ID: 4719669
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
Knopf B; Wätzig V; Knöll B
Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
[TBL] [Abstract][Full Text] [Related]
13. [Experiences with DNCB sensitization in normal human individuals of various age groups (author's transl)].
Bürkle PA; Tönnesmann E; Ahnefeld S; Nobbe F; Federlin K
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):153-65. PubMed ID: 134535
[TBL] [Abstract][Full Text] [Related]
14. Skin testing in the assessment of cell-mediated immunity.
Wilson JD
N Z Med J; 1977 Jan; 85(580):41-4. PubMed ID: 265445
[TBL] [Abstract][Full Text] [Related]
15. Studies on the dinitrochlorobenzene (DNCB) sensitization test.
Niwa Y; Niwa H; Kohmura J; Ou DW; Yokoyama MM
Ann Allergy; 1982 Feb; 48(2):108-12. PubMed ID: 7199878
[TBL] [Abstract][Full Text] [Related]
16. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole.
Basch CM; Spitler LE; Engleman EG; Engleman EP
J Rheumatol; 1977; 4(4):377-88. PubMed ID: 604477
[TBL] [Abstract][Full Text] [Related]
17. [Immune response in the course of Kaposi's sarcoma].
Scalise G; Mura MS; Piersimoni C; Manca S; Cherchi G; Andreoni G
Boll Ist Sieroter Milan; 1980; 59(6):632-7. PubMed ID: 7236363
[TBL] [Abstract][Full Text] [Related]
18. The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis.
Hughes P; Holt S; Rowell NR; Allonby ID; Janis K; Dodd JK
Clin Exp Immunol; 1977 May; 28(2):233-40. PubMed ID: 301448
[TBL] [Abstract][Full Text] [Related]
19. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immunity in Hurler's syndrome.
Mendes E; Toledo SP
Allergol Immunopathol (Madr); 1975; 3(2):95-8. PubMed ID: 808113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
